VR Logo

Nuvation Bio Inc. Class A (NUVB) download report


Others | Others

Nuvation Bio Inc. Class A (NUVB) Premium Coverage

52 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology.

IPO Date: 24-Aug-2020

Founder, Pres, CEO & Director: Dr. David T. Hung M.D.

CFO & Sec.: Ms. Jennifer A. Fox

Listing: NYSE: NUVB

Country: United States

Headquarters: New York, NY

Website: https://www.nuvationbio.com

Key Facts

Market cap: $815.80 Mln

Revenue (TTM): $0.00 Mln

Earnings (TTM): $-87.74 Mln

Cash: $737.70 Mln

Total Debt: $2.79 Mln

Insider's Holding: 27.07%

Liquidity: Low

52 Week range: $3.25 - 10.45

Shares outstanding: 217,128,992

Stock Performance

Time Period Nuvation Bio Inc. Class A (NUVB) S&P BSE Sensex 50 S&P Small-Cap 600
YTD-51.94-9.49-17.79
1 month8.07-3.09-2.72
3 months-23.07-8.74-12.17
1 Year-57.400.23-15.82
3 Years--10.457.14
5 Years--10.656.20
10 Years----10.33
As on 24-Jun-2022
Year Nuvation Bio Inc. Class A (NUVB) S&P Small-Cap 600 S&P BSE Sensex 50
2021-27.3525.2724.31